| abstract |
The present invention relates to a cell treatment agent for muscular tissue regeneration comprising pre-differentiated amniotic fluid stem cells and, more particularly, to a cell treatment agent for sphincter urethrae regeneration comprising, as active ingredients, a mixture of muscle, nerve, and endothelium cells, wherein the three kinds of cells are pre-differentiated in vitro from amniotic fluid stem cells. Also, the present invention relates to a composition comprising pre-differentiated amniotic fluid stem cells for the prevention and treatment of urinary incontinence. The composition, according to the present invention, comprises pre-differentiated amniotic fluid stem cells and has an outstanding effect on the regeneration of muscular tissue, and can thus be effective as a treatment agent for urinary incontinence. |